Literature DB >> 11435845

Anatomical and functional results of pubovaginal sling procedure using polypropylene mesh for the treatment of stress urinary incontinence.

H C Kuo1.   

Abstract

PURPOSE: The anatomical and functional results of pubovaginal sling procedure using polypropylene mesh were investigated.
MATERIALS AND METHODS: A total of 50 women with stress urinary incontinence, including 26 with type 2, 7 with mixed type 2/3 and 17 with type 3 disease, underwent the pubovaginal sling procedure using polypropylene mesh. A self-fashioned 2 cm. polypropylene mesh sling was used in all cases. The slings were fixed without tension at each side of the bladder neck. The sling was further suspended to elevate the bladder neck in patients with type 2 disease and those with a hypermobile bladder base, while it was placed without further tension in those with type 3 disease and those with a nonmobile bladder base. After the operation video urodynamics and transrectal sonography were done to evaluate functional and anatomical results.
RESULTS: At a median followup of 24 months 42 women were cured, 6 had improvement and treatment had failed in 2. Although the maximum flow rate increased, no changes were noted in detrusor pressure, post-void residual urine or cystometric capacity at month 3. Transrectal sonography revealed that mean sling width plus or minus standard deviation had decreased to 13.5 +/- 3.3 mm. at 3 months. The endopelvic fascia was thicker in women with type 2 than in those with types 2/3 or 3 disease (mean 5.3 +/- 1.5 versus 3.5 +/- 1.3 mm., p = 0.001). The position of bladder neck on video urodynamics was elevated a mean of 2.01 +/- 2.01 and 3.07 +/- 2.07 cm. compared to baseline elevation during resting and straining, respectively (p = 0). No hypermobility was noted while the patients coughed and no kinking of the urethra was observed while they performed the Valsalva maneuver. Detrusor instability resolved in 6 of 8 women (75%) and new onset detrusor instability was noted in 7 (14%). In 2 women with persistent stress urinary incontinence a repeat sling procedure was necessary to treat type 3 disease and cure incontinence. The overall success rate was 96%. One patient with sling erosion into the vaginal wall was treated with simple revision.
CONCLUSIONS: Fixation of a polypropylene mesh sling at the bladder neck and adequate suspension may effectively achieve a hammock effect without creating bladder outlet obstruction in patients with types 2 and 2/3 stress urinary incontinence. The anatomical and functional results of this study show that a well suspended bladder neck did not create bladder outlet obstruction after a pubovaginal sling procedure using polypropylene mesh.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435845

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Changes in urodynamic measurements and bladder neck position after single-incision trans-vaginal mesh for pelvic organ prolapse.

Authors:  Hui-Hsuan Lau; Wen-Chu Huang; Yung-Wen Cheng; Hsuan Wang; Tsung-Hsien Su
Journal:  Int Urogynecol J       Date:  2015-07-10       Impact factor: 2.894

2.  Assessing outcome after a modified vaginal wall sling for stress incontinence with intrinsic sphincter deficiency.

Authors:  Elisabetta Costantini; Luigi Mearini; Ettore Mearini; Cinzia Pajoncini; Federico Guercini; Vittorio Bini; Massimo Porena
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-10-22

3.  A prospective study of transobturator tape as treatment for stress urinary incontinence after transvaginal mesh repair.

Authors:  Hui-Hsuan Lau; Tsung-Hsien Su; Wen-Chu Huang; Ching-Hung Hsieh; Chin-Hui Su; Rhu-Chu Chang
Journal:  Int Urogynecol J       Date:  2013-01-12       Impact factor: 2.894

4.  Long-term outcomes of anti-incontinence surgery and subsequent transvaginal sling incision for urethral obstruction.

Authors:  Shu-Yu Wu; Hann-Chorng Kuo
Journal:  Int Urogynecol J       Date:  2018-08-06       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.